Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience

Nekolová, Jana; Rozsíval, P; Šín, Martin; Jirásková, N

doi:10.5507/bp.2017.014

Cited by 11 publications

(20 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…No complications were observed during surgery or in the postoperative period, which is a finding similar to previous studies involving the same ciliary sulcus lens family. 10,11,14,15,24 The design of the tested lenses supports the integrity and physiologic function of the anterior segment of the eye. Intraocular pressure remained practically unchanged in these studies.…”

Section: Discussionmentioning

confidence: 85%

“…Our choice of this supplementary add-on IOL family was justified by that, unlike similar lenses on the market, this platform has been reported to be safe in terms of stable positioning in various eyes, leaving an adequate interlenticular space between the lens and the primary IOL, and involving hardly any complications related to either the surgery or the postoperative course. 10,11,14,15 According to the manufacturer, the 1stQ AddOn diffractive supplementary IOL has an optic similar to the Medicontur Liberty ® 677MY capsular bag IOL, with clinical trifocal performance and spectacle independence of patients being confirmed in related studies. [16][17][18]…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

<p>Spectacle Independence for Pseudophakic Patients – Experience with a Trifocal Supplementary Add-on Intraocular Lens</p>

Palomino-Bautista¹,

Sánchez-Jean²,

González³

et al. 2020

OPTH

View full text Add to dashboard Cite

Purpose: To evaluate the refractive and functional outcomes of the trifocal 1stQ AddOn ® (Medicontur) supplementary intraocular lenses (IOLs) designed for implantation into the ciliary sulcus. Patients and Methods: The study included 18 eyes of 11 pseudophakic patients with uncomplicated previous implantation of monofocal capsular bag IOLs. These patients had a desire for spectacle independence. Distance, intermediate and near visual acuities were measured, and defocus curves were plotted over a period of 6 months following implantation of the add-on IOLs. Intraocular pressure (IOP), endothelial cell density measurements and biomicroscopic evaluation were also performed. Results: In this study, 83.3% of eyes had spherical refractions within ±0.5 D from emetropia and 100% of eyes had spherical equivalent refractions that were within ±1.0 D of the target refraction. Visual acuities and defocus curves clearly confirmed trifocal optical performance (UDVA=0.03 ±0.05; UIVA=0.21 ±0.04; UNVA=0.12 ±0.04 logMAR; expressed as mean ±SD). Depth of focus showed identical results (DOF=0.486 D) compared to a trifocal capsular bag IOL, while the defocus curve was found to be superior in the intermediate and near ranges when compared to a trifocal capsular bag IOL. All patients achieved spectacle independence at all distances. All add-on IOLs were well positioned in the ciliary sulcus. No negative changes were noted in connection with endothelial cell counts, IOPs, the angle structure during surgery and during the follow-up period. Conclusion: The supplementary trifocal add-on IOL seems to be a safe, efficient and stable solution for achieving spectacle independence in pseudophakic patients with monofocal primary IOLs.

show abstract

Section: Discussionmentioning

confidence: 85%

Section: Introductionmentioning

confidence: 99%

<p>Spectacle Independence for Pseudophakic Patients – Experience with a Trifocal Supplementary Add-on Intraocular Lens</p>

Palomino-Bautista¹,

Sánchez-Jean²,

González³

et al. 2020

OPTH

View full text Add to dashboard Cite

show abstract

“…Another solution that can give some function back to patients with geographic atrophy are: Scharioth Macula Lens [19,20] and Implantable Miniature Telescope [21,22] for macular degeneration. A Scharioth Macula Lens is an intraocular lens placed on the sulcus and it has a central addition of +10 dioptres, on a diameter of 12 mm.…”

Section: Discussionmentioning

confidence: 99%

Fundus autofluorescence and multicolour imaging comparison in assessing disease severity in patients suffering from geographic atrophy. A case series analysis

Mallias

Mylova²,

Tassiopoulou³

2017

Ophthalmology J

View full text Add to dashboard Cite

introduCtion. The aim of the study is to determine which depicting modality, fundus autofluorescence or multicolour imaging, is a better diagnostic tool in the monitoring of the progression of geographic atrophy in patients with severe dry macular degeneration. MateriaL and Methods. Fifty patients (93 eyes) participated in this study. OCT examination (Spectralis HRA + OCT, Heidelberg Engineering, Germany) was performed in order to confirm that they fit the criteria to proceed in the study. In all patients, fundus autofluorescence and multicolour imaging was performed. resuLts. The area of geographic atrophy was depicted with both modalities and useful information was obtained. In some cases, multicolour imaging provided more useful clues and in other cases the fundus autofluorescence provided useful information for the progression of the disease. ConCLusions. Both modalities provide a wide range of useful information about the progression of geographic atrophy in patients with severe dry age-related macular degeneration and should both be performed in order to gather all the useful information about the disease progression.

show abstract

“…Schariothova makulární čočka byla těmto pacientům implantována z důvodu zvětšení sledovaného objektu tak, že je umožněn dopad obrazu na zachovalou paramakulární část sítnice, když centrum sítnice je poškozeno [3,7,9]. Základním faktorem je správná indikace a edukace pacientů.…”

Section: Diskuseunclassified

“…add-on nitrooční čočka, její haptiky se umísťují do sulku. Základem úspěchu je především správná indikace a motivace pacienta k následné rehabilitaci [7].…”

unclassified

Methods of Improving the Visual Functions in Patients with Stable Maculopathy – Pilot Results of a New Study

Nekolová

Kremláček

Kuba

et al. 2019

CSO

View full text Add to dashboard Cite

Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience

Abstract: The SML is a new hope for low-vision patients. It acts as a magnifier in the eye. It is a suitable method for increasing near visual acuity in patients with inactive maculopathy.

Cited by 11 publications

References 15 publications

<p>Spectacle Independence for Pseudophakic Patients – Experience with a Trifocal Supplementary Add-on Intraocular Lens</p>

<p>Spectacle Independence for Pseudophakic Patients – Experience with a Trifocal Supplementary Add-on Intraocular Lens</p>

Fundus autofluorescence and multicolour imaging comparison in assessing disease severity in patients suffering from geographic atrophy. A case series analysis

Methods of Improving the Visual Functions in Patients with Stable Maculopathy – Pilot Results of a New Study

Contact Info

Product

Resources

About